Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies
/in Hyperthermia, International Publications /von 2016-03-26 / Semin. Cancer Biol. 2016 06;37-38:96-105Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC
/in Hyperthermia, International Publications, NSCLC /von 2016-03-24 / Thorac Cancer 2016 Jul;7(4):422-7Expertenbericht von Prof. Dr. Schirrmacher, Wiener klinisches Magazin
/in IOZK In der Presse, IOZK Veröffentlichungen /von IOZKAntigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2016-03-07 / Tumour Biol. 2016 Aug;37(8):11267-78Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-20Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
/in Dendritic Cells, Glioblastoma, Immunogenic Cell Death, International Publications, Prostate Cancer /von 2016-03-02 / Sci Transl Med 2016 Mar;8(328):328ra27Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
/in Dendritic Cells, HIV/AIDS, International Publications /von 2016-03-01 / J. Acquir. Immune Defic. Syndr. 2016 Mar;71(3):246-53Hyperthermia: How Can It Be Used?
/in Hyperthermia, International Publications /von 2016-03-01 / Oman Med J 2016 Mar;31(2):89-97
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de